New Leaf Venture Partners, L.L.C. Edgewise Therapeutics, Inc. Transaction History
New Leaf Venture Partners, L.L.C.
- $74.2 Million
- Q4 2024
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 1,030,161 shares of EWTX stock, worth $13.9 Million. This represents 37.07% of its overall portfolio holdings.
Number of Shares
1,030,161
Previous 1,553,661
33.69%
Holding current value
$13.9 Million
Previous $41.5 Million
33.67%
% of portfolio
37.07%
Previous 42.79%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
220Shares Held
98.2MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$202 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$120 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$82.8 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$80.9 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$67.3 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $850M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...